The Patent Finder

Method of Treating Solid Cancers with Pegylated IL-10

Schering Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,364,517Method of treatment of lymphoma with Pegylated IL-10
In force
 · Medium confidence
UsedRemaining
Merck Sharp & Dohme Corp.In forceMedium confidence
US 9,833,514Use of Pegylated IL-10 to Treat Cancer
In force
 · Medium confidence
Merck Sharp & Dohme Corp.In forceMedium confidence
US 10,568,968Methods for Treatment of Cancer with Therapeutic Combinations Comprising PEG-IL-10
In force
 · Medium confidence
Merck Sharp & Dohme Corp.In forceMedium confidence
US 8,865,652Method of Treating Solid Cancers with Pegylated IL-10
In force
 · Medium confidence
Merck Sharp & Dohme Corp.In forceMedium confidence
Application 11/862,626Use of Pegylated IL-10 to Treat Cancer
Abandoned
Abandoned Aug 28, 2009
Schering CorporationAbandonedAbandoned Aug 28, 2009
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Schering Corporation.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited